ResearcherMayo ClinicActive in the last 2 years
Andrea Zironda
Matched on ORCID iD 0000-0002-0874-1861; OpenAlex author ID A5086618644. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2024: 3 papers · 2025: 4 papers
Papers 7
- Financial Toxicity of Long-Term Survivors Who Underwent Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. First author DOI 10.1002/jso.27871↗
- The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study. Co-author DOI 10.1016/j.annonc.2024.12.015↗
- Prediction of early recurrence as a marker of surgical futility in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.suronc.2025.102208↗
- Artery-First Approach During Minimally Invasive Pancreatoduodenectomy for Pancreatic Cancer: Outcomes from a Single Center and Comparison Between Laparoscopic … Co-author DOI 10.3390/cancers17132103↗
- Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients undergoing curative intent resection. Co-author DOI 10.1016/j.hpb.2023.09.010↗
- Quality of Life and Gastrointestinal Symptoms in Long-term Survivors of Pancreatic Cancer Following Pancreatoduodenectomy. First author DOI 10.1097/sla.0000000000006053↗
- Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma. First author DOI 10.1245/s10434-023-14875-5↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sean Patrick Cleary · 4 shared papers, 2024–2025 · strength 0.84
- Paper Financial Toxicity of Long-Term Survivors Who Underwent Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. DOI 10.1002/jso.27871↗
- Paper Quality of Life and Gastrointestinal Symptoms in Long-term Survivors of Pancreatic Cancer Following Pancreatoduodenecto… DOI 10.1097/sla.0000000000006053↗
- Paper Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients u… DOI 10.1016/j.hpb.2023.09.010↗
- Susanne Gray Warner · 4 shared papers, 2024–2025 · strength 0.84
- Paper Financial Toxicity of Long-Term Survivors Who Underwent Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. DOI 10.1002/jso.27871↗
- Paper Quality of Life and Gastrointestinal Symptoms in Long-term Survivors of Pancreatic Cancer Following Pancreatoduodenecto… DOI 10.1097/sla.0000000000006053↗
- Paper Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients u… DOI 10.1016/j.hpb.2023.09.010↗
- Cornelius A. Thiels · 4 shared papers, 2024–2025 · strength 0.84
- Paper Financial Toxicity of Long-Term Survivors Who Underwent Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. DOI 10.1002/jso.27871↗
- Paper Quality of Life and Gastrointestinal Symptoms in Long-term Survivors of Pancreatic Cancer Following Pancreatoduodenecto… DOI 10.1097/sla.0000000000006053↗
- Paper Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients u… DOI 10.1016/j.hpb.2023.09.010↗
- Mark Joseph Truty · 4 shared papers, 2024–2025 · strength 0.84
- Paper Financial Toxicity of Long-Term Survivors Who Underwent Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. DOI 10.1002/jso.27871↗
- Paper Quality of Life and Gastrointestinal Symptoms in Long-term Survivors of Pancreatic Cancer Following Pancreatoduodenecto… DOI 10.1097/sla.0000000000006053↗
- Paper Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients u… DOI 10.1016/j.hpb.2023.09.010↗
- Chi Zhang · 3 shared papers, 2024–2025 · strength 0.65
- Paper Financial Toxicity of Long-Term Survivors Who Underwent Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. DOI 10.1002/jso.27871↗
- Paper Quality of Life and Gastrointestinal Symptoms in Long-term Survivors of Pancreatic Cancer Following Pancreatoduodenecto… DOI 10.1097/sla.0000000000006053↗
- Paper Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients u… DOI 10.1016/j.hpb.2023.09.010↗
- Michael L. Kendrick · 3 shared papers, 2024–2025 · strength 0.64
- Paper Financial Toxicity of Long-Term Survivors Who Underwent Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. DOI 10.1002/jso.27871↗
- Paper Quality of Life and Gastrointestinal Symptoms in Long-term Survivors of Pancreatic Cancer Following Pancreatoduodenecto… DOI 10.1097/sla.0000000000006053↗
- Paper Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancrea… DOI 10.1245/s10434-023-14875-5↗
- Michele Mazzola · 2 shared papers, 2025 · strength 0.49
- Giovanni Carlo Ferrari · 2 shared papers, 2025 · strength 0.49
- Hala Muaddi · 1 shared paper, 2025 · strength 0.24
- Davide Citterio · 1 shared paper, 2025 · strength 0.23
- Vincenzo Mazzaferro · 1 shared paper, 2025 · strength 0.23
- Samuele Grandi · 1 shared paper, 2025 · strength 0.23
- Giuseppe Leoncini · 1 shared paper, 2025 · strength 0.23
- Robert R. McWilliams · 1 shared paper, 2024 · strength 0.20
- Amro M. Abdelrahman · 1 shared paper, 2024 · strength 0.19
- Travis Edward Grotz · 1 shared paper, 2024 · strength 0.19
- Alessandro Fogliati · 1 shared paper, 2024 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.